Leonard Scott Dove Net Worth

What's Leonard Dove's mailing address?

Leonard's mailing address filed with the SEC is C/O ARAVIVE, INC., RIVER OAKS TOWER,, 3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098.

Insiders trading at Aravive Inc

Over the last 6 years, insiders at Aravive Inc have traded over $107,045 worth of Aravive Inc stock and bought 151,333 units worth $1,102,898 . The most active insiders traders include Srinivas Akkaraju, Fredric N Eshelman Ventures... oraz Shahzad Malik. On average, Aravive Inc executives and independent directors trade stock every 75 days with the average trade being worth of $11,962. The most recent stock trade was executed by Fredric N Eshelman Ventures... on 1 April 2022, trading 4,545,455 units of ARAV stock currently worth $181,818.

What does Aravive Inc do?

versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.

Aravive Inc executives and stock owners

Aravive Inc executives and other stock owners filed with the SEC include:

• Gail McIntyre,
  President, Chief Executive Officer, Director
• Vinay Shah,
  Chief Financial Officer
• Dr. Gail F. McIntyre CH (ASCP), DABT, Ph.D.,
  Pres, CEO & Director
• Dr. Reshma Rangwala M.D., Ph.D.,
  Chief Medical Officer
• Amato Giaccia,
  Independent Director
• Raymond Tabibiazar,
  Independent Director
• Eric Zhang,
  Independent Director
• Dr. Fredric N. Eshelman Pharm.D.,
  Exec. Chairman
• Mike Zanoni,
  IR Contact Officer
• Michael Rogers,
  Director
• Reshma Rangwala,
  Chief Medical Officer
• Fredric Eshelman,
  Independent Chairman of the Board
• Kenneth L. Guernsey,
  Sec.
• Dr. Randy L. Anderson,
  Sr. VP of Data Sciences
• Joseph T. Schepers,
  VP of Investor Relations
• Dr. Joshua Silverman Ph.D.,
  Co-Founder
• Dr. Jeffrey L. Cleland,
  Co-Founder
• Maria Carolina Petrini,
  Chief Commercial Officer
• Robert B. Geller,
  Chief Medical Officer
• Leonard Scott Dove,
  Chief Operating Officer
• Rekha Hemrajani,
  
• Srinivas Akkaraju,
  Director
• Jay Shepard,
  President and CEO
• Kevin Haas,
  VP, Finance and PAO
• Shahzad Malik,
  Director
• Robert Hoffman,
  Director
• Peter Tai Ching Ho,
  Director
• John Hohneker,
  Director
• Sigurd Kirk,
  Director
• Rudy Howard,
  Chief Financial Officer